Latest: Watch here for details of new products and services.
- About Us
- Pharmalicensing - Open Innovation for the life sciences
- Our Products
- Overview
- Partnering Search
- Company Profiling
- Partneringtools
- Reports
- Partnering Consulting
- Due Diligence
- Comparison
- Due Diligence
- Overview
- Top Applications
- Online Panel Discussions
- Request Consultation
- Case Studies
- See what others think about our service
- Newsletter
- Partnering update
- Key reports
- Subscribe
- Quick Links
- Profile now
- Register now
- Profiled companies
- Featured events
- Industry news
- PR Newswire
- Jobs
- Forums
- Contact Pharmalicensing
- Send an email
- Call us: +44 1904 520460
- Request a callback
- RSS Feeds
- Keep up to date
Pharmalicensing Ltd
is a division of
is a division of
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
Cellophil (TM) is particularly designed for optical lenses, drug delivery and also may be used as additive for food and cosmetics or as fiber for fabrics. More
pH maintenance, Spermicide, Microbicide Lubricant More
rHu EPO More
Phytohealth Corporation: PH3 (PHN031, PHN033) - For osteoporosis and diabetic vascular complications
Patented technology regarding new and safe mechanism with the active substance PH3 for the indications of osteoporosis and diabetic vascular complications. More
Adult autologous myoblasts cell suspension More
A number of select phospho-peptides that are derived from the crystal-inhibiting protein osteopontin and that have a distinct set of structural criteria. More
This invention concerns the oral and intravenous administration of sodium 2-mercaptoethylsulfonate (MESNA) in the treatment of hyperhomocysteinemia. More
New methods for treating, minimizing and/or preventing inflammatory injury mediated by the activity of interleukin 2 (IL-2) on non-T cells, such as epithelial cells, expressing IL-2 receptors (IL-2R) More
Adrenomedullin peptides and antibodies, which would be useful in the development of a therapeutic or for diagnostics use More
Methods of administering N-acetylmannosamine or its derivative to treat muscular atrophy More
Your selection
Browse By
- Industry sector
- Assay systems
- Diagnostic test systems
- Gene therapy
- Human diagnostics
- Human therapeutics
- Nanotechnology
- Other
- Research supplies
- Stem cells
- Therapeutic target
- Diabetic nephropathy
- Dialysis
- Diuretic
- Gallstones
- Hemolytic uremic syndrome
- Incontinence
- Interstitial cystitis
- Kidney disorder (other)
- Pollakiuria
- Renal disease
- Renal failure
- Urinary incontinence/urgency
- Urinary tract disorder (other)
- Urinary tract infection
- Development phase
- Early Stage
- Preclinical
- Phase I
- Phase I/II
- Phase II
- Phase III
- Phase III/IV
- Preregistration
- Registered
© Copyright 1995-2008 Pharmalicensing Ltd, is a division of 
All rights reserved. Terms and Conditions | Site map | Contact us